妇科恶性肿瘤保留生育功能生育结局  

Reproductive outcomes of fertility-sparing treatment for gynecologic malignancies

作　　者：薛凤霞[1] 滕飞[1] 魏丽坤[1] XUE Feng-xia;TENG Fei;WEI Li-kun(Tianjin Medical University General Hospital,Tianjin 300052,China)

机构地区：[1]天津医科大学总医院妇产科,天津300052

出　　处：《中国实用妇科与产科杂志》2019年第6期646-651,共6页Chinese Journal of Practical Gynecology and Obstetrics

基　　金：国家自然科学基金(81572568;81772790);天津市自然科学基金(18JCQNJC81200)

摘　　要：子宫颈癌、子宫内膜癌和卵巢癌是妇科常见的三大恶性肿瘤,近年来随着发病的年轻化及女性育龄的推迟,保留生育功能的治疗在妇科恶性肿瘤患者中的应用越来越广泛。在妇科恶性肿瘤保留生育功能的临床诊治中,需联合多学科协作诊疗,在不增加肿瘤复发的情况下,保留患者生育功能,制定个体化治疗方案,提供最佳的生育指导,改善生育结局。Cervical cancer,endometrial cancer and ovarian cancer are common gynecologic malignancies.Recently,with the younger onset age and delay of childbearing,the fertility-sparing treatment has been increasingly used.In the fertility-sparing treatment for gynecologic malignancies,we should protect the fertility of patients without increasing tumor recurrence,which requires the multidisciplinary cooperation to develop individualized treatment strategy,provide optimal reproductive guidance and finally improve the reproductive outcomes.

关 键 词：子宫颈癌 子宫内膜癌 卵巢癌 保留生育功能 生育结局 

分 类 号：R737.3[医药卫生—肿瘤]